Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
NCR Voyix
VYX
$1.12B
| $2.8M | ﹤0.01% |
274,133
+119,730
| +78% | +$1.3M |
|
1652
Marten Transport
MRTN
$1.18B
| $2.79M | ﹤0.01% |
+245,014
| New | +$2.6M |
|
|
PMT
1653
PennyMac Mortgage Investment
PMT
$810M
| $2.79M | ﹤0.01% |
222,172
+49,151
| +28% | +$613K |
|
1654
General Motors
GM
$75.3B
| $2.78M | ﹤0.01% |
34,146
-743,096
| -96% | -$52.4M |
|
1655
PUT
Union Pacific
UNP
$184B
| $2.78M | ﹤0.01% |
12,000
+1,300
| +12% | +$297K |
|
1656
BlackRock Floating Rate Income Strategies Fund
FRA
$388M
| $2.77M | ﹤0.01% |
+235,319
| New | +$2.87M |
|
1657
Applovin
APP
$104B
| $2.77M | ﹤0.01% |
4,110
+1,685
| +69% | +$1.06M |
|
1658
PUT
Upstart Holdings
UPST
$2.98B
| $2.77M | ﹤0.01% |
63,300
-98,900
| -61% | -$4.55M |
|
1659
Autodesk
ADSK
$53B
| $2.75M | ﹤0.01% |
9,301
+3,038
| +49% | +$919K |
|
1660
CALL
United Rentals
URI
$65.6B
| $2.75M | ﹤0.01% |
3,400
+400
| +13% | +$347K |
|
1661
Vera Therapeutics
VERA
$2.54B
| $2.75M | ﹤0.01% |
+54,327
| New | +$1.93M |
|
1662
PUT
Schwab US Dividend Equity ETF
SCHD
$112B
| $2.74M | ﹤0.01% |
+100,000
| New | +$2.72M |
|
1663
PUT
Trip.com Group
TCOM
$29B
| $2.74M | ﹤0.01% |
38,100
+29,400
| +338% | +$2.1M |
|
1664
Recursion Pharmaceuticals
RXRX
$1.91B
| $2.73M | ﹤0.01% |
668,174
+105,726
| +19% | +$524K |
|
1665
AZZ Inc
AZZ
$4.16B
| $2.73M | ﹤0.01% |
+25,425
| New | +$2.63M |
|
1666
PUT
Quantum Computing Inc
QUBT
$1.91B
| $2.72M | ﹤0.01% |
265,400
+115,400
| +77% | +$1.64M |
|
1667
Trump Media & Technology Group
DJT
$2.61B
| $2.71M | ﹤0.01% |
204,628
+116,490
| +132% | +$1.59M |
|
1668
BlackRock MuniYield Quality Fund
MQY
$801M
| $2.7M | ﹤0.01% |
+238,968
| New | +$2.74M |
|
1669
CALL
Procter & Gamble
PG
$338B
| $2.69M | ﹤0.01% |
18,800
+5,200
| +38% | +$767K |
|
1670
PUT
Dollar Tree
DLTR
$25.8B
| $2.68M | ﹤0.01% |
21,800
-256,500
| -92% | -$27.5M |
|
1671
Energy Services of America
ESOA
$215M
| $2.68M | ﹤0.01% |
328,148
-91,312
| -22% | -$878K |
|
|
CTRA
1672
PUT
DELISTED
Coterra Energy
CTRA
| $2.66M | ﹤0.01% |
+101,200
| New | +$2.55M |
|
1673
Sutro Biopharma
STRO
$356M
| $2.66M | ﹤0.01% |
+230,049
| New | +$2.18M |
|
1674
Relmada Therapeutics
RLMD
$490M
| $2.65M | ﹤0.01% |
+547,854
| New | +$1.84M |
|
1675
CALL
Eaton
ETN
$159B
| $2.64M | ﹤0.01% |
8,300
-1,500
| -15% | -$532K |
|
Similar funds
Dmitry Balyasny's Q4 2025 Portfolio in Review
As of Q4 2025, Dmitry Balyasny held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Dmitry Balyasny withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Dmitry Balyasny opened a new position in Avidity Biosciences worth $436M.
- Dmitry Balyasny's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Dmitry Balyasny added most to Amazon in Q4 2025, an estimated $807M increase.
- Dmitry Balyasny's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Dmitry Balyasny fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Dmitry Balyasny's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Dmitry Balyasny opened 809 new positions and closed 643 in Q4 2025.
- Dmitry Balyasny's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.